Cryptococcal Pneumonia in a Patient on Tyrosine Kinase Inhibitor Therapy: How Common Is It?

Area of Science:

• Mycology
• Infectious Diseases
• Pulmonology

Background:

• Cryptococcal pneumonia is a fungal lung infection caused by Cryptococcus species.
• Cryptococcus neoformans typically affects immunocompromised individuals.
• Cryptococcus gattii infections are more common in immunocompetent hosts.

Observation:

• A 76-year-old male with chronic lymphocytic leukemia was treated with ibrutinib.
• The patient experienced multiple hospitalizations for pneumonia.
• Diagnosis was confirmed via bronchoalveolar lavage fungal culture and lymph node biopsy.

Findings:

• The patient was diagnosed with cryptococcal pneumonia.
• This case represents a less common presentation of Cryptococcus neoformans infection in an immunocompromised patient on targeted therapy.

Implications:

• Highlights the importance of considering fungal infections in immunocompromised patients, even those on novel therapies.
• Suggests potential diagnostic challenges and the need for definitive microbiological confirmation.
• Underscores the diverse clinical presentations of cryptococcal pneumonia.